CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as $8.10 per share

CVS Health's second quarter net income nearly tripled to $2.9 billion compared to the year ago quarter as the company gets a better handle on its Aetna health plan costs.

CVS also announced a new collaboration with Eli Lilly that will make Zepbound and Foundayo accessible to eligible patients on the CVS Health app.